Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: Pharmacodynamic implications
10.1128/AAC.50.3.874-879.2006
Saved in:
Main Authors: | Zhou, X.-J., Lim, S.-G., Lloyd, D.M., Chao, G.C., Brown, N.A., Lai, C.-L. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/132533 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies
by: Ho, Jingshan, et al.
Published: (2022) -
Telbivudine versus lamivudine in patients with chronic hepatitis B
by: Ching Lung Lai, et al.
Published: (2018) -
Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization
by: Nicholas J. White
Published: (2018) -
Treatment of hepatitis B e antigen-positive chronic hepatitis with telbivudine or adefovir: A randomized trial
by: Chan, H.L.Y., et al.
Published: (2016) -
Telbivudine: A hepatitis B-specific antiviral
by: Lim, S.G.
Published: (2011)